|
| |
MorphoSys AGMorphoSys AG, located in Martinsried/Munich, is one of the world's leading biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next generation of antibodies, which can be used to treat diseases and for research and diagnostics purposes. Numerous partnerships have already been entered into with well-known companies from the pharmaceutical and biotechnology sectors, such as Bayer, Boehringer Ingelheim, Centocor/Johnson & Johnson, Daiichi Sankyo, Novartis, Pfizer, Roche and Schering.The Company, founded in 1992, possesses the unique HuCAL technology (the Human Combinatorial Antibody Library). This library comprises more than ten billion different, fully human antibodies. HuCAL is a very powerful technology, which allows rapid and automated production of high-affinity antibodies. The most important feature of the library is its capability of optimizing fully human antibodies to meet predefined specifications.
| Contact Details: |
| Lena-Christ-Strasse 48 |
| Martinsried |
| Planegg |
| 82152 |
| Germany |
| Tel: | 49 (0)89 / 899 27-0 |
| Fax: | 49 (0)89 / 899 27-222 |
| Email: | investors@morphosys.com |
| WWW: | www.morphosys.com/
|
| |
Recent Publications by MorphoSys AG: |  |
The Role of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 in the p38/TNF-alpha Pathway of Systemic and Cutaneous Inflammation.
Mitogen-activated protein kinase-activated protein kinase 2 (MK2) is a... | 7th August, 2009
| MorphoSys AG, Martinsried, Germany.
| J Invest Dermatol. 2009 Aug 6.
DOI Direct Link |
In vitro affinity maturation of human GM-CSF antibodies by targeted CDR-diversification.
The mammalian immune system applies somatic hypermutation to select for... | 9th April, 2009
| MorphoSys AG, Lena-Christ-Str. 48, Martinsried 82152, Germany.
| Mol Immunol. 2008 Nov;46(1):135-44. Epub 2008 Aug 21.
DOI Direct Link |
Recombinant monoclonal antibodies.
Recombinant antibody technology is a rapidly evolving field that enables... | 12th August, 2008
| Department of Research, MorphoSys AG, Martinsried, Germany.
| Methods Mol Biol. 2007;378:14-31.
|
The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
This article describes the generation of the Human Combinatorial Antibody... | 20th March, 2008
| MorphoSys AG, Lena-Christ-Strasse 48, 82152 Martinsried, Germany.
| J Mol Biol. 2008 Feb 29;376(4):1182-200. Epub 2007 Dec 15.
DOI Direct Link |
Generation and optimization of human antagonistic antibodies against TIMP-1 as potential therapeutic agents in fibrotic diseases.
Impaired matrix metalloproteinase 1 (MMP-1) function, as result of the... | 22nd August, 2007
| MorphoSys AG, Lena-Christ-Str. 48, 82152 Martinsried/Planegg, Germany.
| Hum Antibodies. 2006;15(4):115-24.
|
→View more MorphoSys AG research publications. |
Press Releases on MorphoSys AG:
|
 |
| DSM Biologics and MorphoSys AG to Manufacture Fully Human Antibody |
12th August, 2008 |
DSM Biologics |
PARSIPPANY, N.J., Aug. 12 /PRNewswire/ -- DSM Biologics and MorphoSys AG
(Frankfurt Stock Exchange: MOR; Prime Standard Segment, TecDAX) today
announced the signing of a Biopharmaceutical
|
| BIO Deutschland: Independent Biotechnology Industry Organisation Founded |
1st October, 2004 |
Bio Deutschland |
BIO Deutschland: Independent Biotechnology Industry Organisation Founded
29
October 2004 Berlin - Leading companies from the German biotechnology
sector have established a new and independent
|
| MorphoSys Reports third quarter 2004 results. Company expects to obtain
|
1st September, 2004 |
Morphosys |
MorphoSys
Reports third quarter 2004 results. Company expects to obtain profitablity by
2005
Martinsried/Munich, October 28,
2004 MorphoSys AG (Frankfurt Stock Exchange: MOR; Prime
|
| MorphoSys Generated Antibody Approved to Enter Clinical Trials |
1st January, 1970 |
Morphosys |
MorphoSys Generated Antibody
Approved to Enter Clinical Trials
Martinsried/Munich, December 09, 2004 -
MorphoSys AG (Frankfurt Stock Exchange: MOR; Prime Standard Segment; TecDAX)
|
| MorphoSys Antibodies by Design, ProQinase and Natural and Medical
|
1st January, 1970 |
Morphosys |
MorphoSys Antibodies by Design,
ProQinase and Natural and Medical Sciences Institute (NMI) receive BMBF-promotion
for Kinome-project
ASK-chip shall enable targeted functional
analysis of
|
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 394 times since April 2007, the link to the organisation's website has been followed 59 times Recent Search Terms used to find this page: Simultaneous metal chelate affinity purification and endotoxin | MorphoSys download | antibody affinity maturation company list | . Search for more companies in Martinsried Search for more companies in Planegg This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for MorphoSys AG |
